MoonLake Immunotherapeutics Class A Ordinary Shares

Go to MoonLake Immunotherapeutics Class A Ordinary Shares Website

$45.26

(%)
Live
Previous Close

$45.26

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$2.8 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. The company derives maximum reve...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day

Related tickers: MLTX.

Read Full Article

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024

Related tickers: MLTX.

Read Full Article
Trending Tickers
LASE

XNAS

$2.04
(%)
PACW

XNAS

$7.54
(%)
SMFL

XNAS

$3.58
(%)
SQ

XNYS

$69.47
(%)
MLGO

XNAS

$0.00
(%)